(Reuters) - The compound, ABT-888, is designed to help cancer drugs
work better by preventing cancer cells from fighting off the
treatment.
"It's a highly potent compound," Dr. Shivaani Kummar, a
researcher with the National Cancer Institute Center for Cancer
Research, said in an interview on Monday.
Read more at Reuters.com Government Filings News
work better by preventing cancer cells from fighting off the
treatment.
"It's a highly potent compound," Dr. Shivaani Kummar, a
researcher with the National Cancer Institute Center for Cancer
Research, said in an interview on Monday.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment